Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-24

Clinical Trial Update: Prevention of Transmission of Hepatitis C Virus (HCV) From HCV-Viremic Organ Donor [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on preventing transmission of hepatitis C from an HCV-viremic organ donor; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: Hepatitis C, Hepatitis C Virus Infection, Response to Therapy of | Phase 1, Phase 2 | Status: COMPLETED